Coactivator-associated arginine methyltransferase 1 (CARM1) was recruited by hypoxia-inducible factor 1 subunit alpha (HIF1A) to form a complex and transactivate CDK4 and HIF1A through epigenetic regulatory mechanisms. The molecular basis of CARM1 in TNBC carcinogenesis and the effective natural inhibitor were determined, which may provide new ideas for the TNBC therapy. Credit: Dandan Feng, Jie Gao, Ruiqiong Liu, Wei Liu, Tianyang Gao, Yunkai Yang, Die Zhang, Tianshu Yang, Xin Yin, Hefen Yu, Wei Huang, and Yan Wang A study published in the journal Protein & Cell includes an introduction to Read More
